These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 14719104)
1. Expression of CD97 and CD55 in human medullary thyroid carcinomas. Mustafa T; Klonisch T; Hombach-Klonisch S; Kehlen A; Schmutzler C; Koehrle J; Gimm O; Dralle H; Hoang-Vu C Int J Oncol; 2004 Feb; 24(2):285-94. PubMed ID: 14719104 [TBL] [Abstract][Full Text] [Related]
2. Expression of the epidermal growth factor seven-transmembrane member CD97 correlates with grading and staging in human oral squamous cell carcinomas. Mustafa T; Eckert A; Klonisch T; Kehlen A; Maurer P; Klintschar M; Erhuma M; Zschoyan R; Gimm O; Dralle H; Schubert J; Hoang-Vu C Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):108-19. PubMed ID: 15668483 [TBL] [Abstract][Full Text] [Related]
3. The expression of CD97EGF and its ligand CD55 on marginal epithelium is related to higher stage and depth of tumor invasion of gastric carcinomas. Liu Y; Chen L; Peng S; Chen Z; Gimm O; Finke R; Hoang-Vu C Oncol Rep; 2005 Dec; 14(6):1413-20. PubMed ID: 16273233 [TBL] [Abstract][Full Text] [Related]
4. Expression of the EGF-TM7 receptor CD97 and its ligand CD55 (DAF) in multiple sclerosis. Visser L; de Vos AF; Hamann J; Melief MJ; van Meurs M; van Lier RA; Laman JD; Hintzen RQ J Neuroimmunol; 2002 Nov; 132(1-2):156-63. PubMed ID: 12417446 [TBL] [Abstract][Full Text] [Related]
5. Role of CD97(stalk) and CD55 as molecular markers for prognosis and therapy of gastric carcinoma patients. Liu Y; Chen L; Peng SY; Chen ZX; Hoang-Vu C J Zhejiang Univ Sci B; 2005 Sep; 6(9):913-8. PubMed ID: 16130195 [TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression and prognostic value of CD97 and its ligand CD55 in primary gallbladder carcinoma. Wu J; Lei L; Wang S; Gu D; Zhang J J Biomed Biotechnol; 2012; 2012():587672. PubMed ID: 22547928 [TBL] [Abstract][Full Text] [Related]
7. The seven-span transmembrane receptor CD97 has a cellular ligand (CD55, DAF). Hamann J; Vogel B; van Schijndel GM; van Lier RA J Exp Med; 1996 Sep; 184(3):1185-9. PubMed ID: 9064337 [TBL] [Abstract][Full Text] [Related]
8. Tissue distribution of the human CD97 EGF-TM7 receptor. Jaspars LH; Vos W; Aust G; Van Lier RA; Hamann J Tissue Antigens; 2001 Apr; 57(4):325-31. PubMed ID: 11380941 [TBL] [Abstract][Full Text] [Related]
9. Characterization of the CD55 (DAF)-binding site on the seven-span transmembrane receptor CD97. Hamann J; Stortelers C; Kiss-Toth E; Vogel B; Eichler W; van Lier RA Eur J Immunol; 1998 May; 28(5):1701-7. PubMed ID: 9603477 [TBL] [Abstract][Full Text] [Related]
10. Structural characterization of mouse CD97 and study of its specific interaction with the murine decay-accelerating factor (DAF, CD55). Qian YM; Haino M; Kelly K; Song WC Immunology; 1999 Oct; 98(2):303-11. PubMed ID: 10540231 [TBL] [Abstract][Full Text] [Related]
11. Expression of the activation antigen CD97 and its ligand CD55 in rheumatoid synovial tissue. Hamann J; Wishaupt JO; van Lier RA; Smeets TJ; Breedveld FC; Tak PP Arthritis Rheum; 1999 Apr; 42(4):650-8. PubMed ID: 10211878 [TBL] [Abstract][Full Text] [Related]
12. Selective expression of a splice variant of decay-accelerating factor in c-erbB-2-positive mammary carcinoma cells showing increased transendothelial invasiveness. Brandt B; Mikesch JH; Simon R; Rötger A; Kemming D; Schier K; Sauter G; Bürger H Biochem Biophys Res Commun; 2005 Apr; 329(1):318-23. PubMed ID: 15721309 [TBL] [Abstract][Full Text] [Related]
13. N-glycosylation of CD97 within the EGF domains is crucial for epitope accessibility in normal and malignant cells as well as CD55 ligand binding. Wobus M; Vogel B; Schmücking E; Hamann J; Aust G Int J Cancer; 2004 Dec; 112(5):815-22. PubMed ID: 15386373 [TBL] [Abstract][Full Text] [Related]
14. CD97: a dedifferentiation marker in human thyroid carcinomas. Aust G; Eichler W; Laue S; Lehmann I; Heldin NE; Lotz O; Scherbaum WA; Dralle H; Hoang-Vu C Cancer Res; 1997 May; 57(9):1798-806. PubMed ID: 9135025 [TBL] [Abstract][Full Text] [Related]
15. Analysis of membrane-bound complement regulatory proteins in prostate cancer. Loberg RD; Wojno KJ; Day LL; Pienta KJ Urology; 2005 Dec; 66(6):1321-6. PubMed ID: 16360477 [TBL] [Abstract][Full Text] [Related]
16. Human EMR2, a novel EGF-TM7 molecule on chromosome 19p13.1, is closely related to CD97. Lin HH; Stacey M; Hamann J; Gordon S; McKnight AJ Genomics; 2000 Jul; 67(2):188-200. PubMed ID: 10903844 [TBL] [Abstract][Full Text] [Related]
17. CD97, but not its closely related EGF-TM7 family member EMR2, is expressed on gastric, pancreatic, and esophageal carcinomas. Aust G; Steinert M; Schütz A; Boltze C; Wahlbuhl M; Hamann J; Wobus M Am J Clin Pathol; 2002 Nov; 118(5):699-707. PubMed ID: 12428789 [TBL] [Abstract][Full Text] [Related]
18. Structural and functional characterization of a novel T cell receptor co-regulatory protein complex, CD97-CD55. Abbott RJ; Spendlove I; Roversi P; Fitzgibbon H; Knott V; Teriete P; McDonnell JM; Handford PA; Lea SM J Biol Chem; 2007 Jul; 282(30):22023-32. PubMed ID: 17449467 [TBL] [Abstract][Full Text] [Related]
19. Regulation of CD97 protein in thyroid carcinoma. Hoang-Vu C; Bull K; Schwarz I; Krause G; Schmutzler C; Aust G; Köhrle J; Dralle H J Clin Endocrinol Metab; 1999 Mar; 84(3):1104-9. PubMed ID: 10084602 [TBL] [Abstract][Full Text] [Related]
20. Identification of the epidermal growth factor-TM7 receptor EMR2 and its ligand dermatan sulfate in rheumatoid synovial tissue. Kop EN; Kwakkenbos MJ; Teske GJ; Kraan MC; Smeets TJ; Stacey M; Lin HH; Tak PP; Hamann J Arthritis Rheum; 2005 Feb; 52(2):442-50. PubMed ID: 15693006 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]